
Harris C. Wang
Examiner (ID: 9046, Phone: (571)270-1462 , Office: P/2439 )
| Most Active Art Unit | 2439 |
| Art Unit(s) | 2139, 2439 |
| Total Applications | 625 |
| Issued Applications | 416 |
| Pending Applications | 50 |
| Abandoned Applications | 179 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20287492
[patent_doc_number] => 20250312735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-09
[patent_title] => DEVICES, METHODS, AND SYSTEMS FOR CAPTURING AND SEQUESTERING ATMOSPHERIC GASES
[patent_app_type] => utility
[patent_app_number] => 19/244168
[patent_app_country] => US
[patent_app_date] => 2025-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19244168
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/244168 | DEVICES, METHODS, AND SYSTEMS FOR CAPTURING AND SEQUESTERING ATMOSPHERIC GASES | Jun 19, 2025 | Pending |
Array
(
[id] => 20277672
[patent_doc_number] => 20250302914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-02
[patent_title] => ELECTROPORATION-TARGETED DELIVERY OF RIBOSOME INACTIVATING PROTEIN GELONIN INTO MAMMALIAN CELLS
[patent_app_type] => utility
[patent_app_number] => 19/089650
[patent_app_country] => US
[patent_app_date] => 2025-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19089650
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/089650 | ELECTROPORATION-TARGETED DELIVERY OF RIBOSOME INACTIVATING PROTEIN GELONIN INTO MAMMALIAN CELLS | Mar 24, 2025 | Pending |
Array
(
[id] => 19641379
[patent_doc_number] => 20240415899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS
[patent_app_type] => utility
[patent_app_number] => 18/820753
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18820753
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/820753 | Bacteriotherapy for clostridium difficile colitis | Aug 29, 2024 | Issued |
Array
(
[id] => 19528504
[patent_doc_number] => 20240352406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => BIOCOMPATIBLE CONDITIONED CELL MEDIUM COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/639518
[patent_app_country] => US
[patent_app_date] => 2024-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639518
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/639518 | BIOCOMPATIBLE CONDITIONED CELL MEDIUM COMPOSITIONS AND USES THEREOF | Apr 17, 2024 | Pending |
Array
(
[id] => 19528511
[patent_doc_number] => 20240352413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/639238
[patent_app_country] => US
[patent_app_date] => 2024-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/639238 | ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF | Apr 17, 2024 | Pending |
Array
(
[id] => 19528511
[patent_doc_number] => 20240352413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/639238
[patent_app_country] => US
[patent_app_date] => 2024-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/639238 | ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF | Apr 17, 2024 | Pending |
Array
(
[id] => 19343593
[patent_doc_number] => 20240252556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS
[patent_app_type] => utility
[patent_app_number] => 18/631959
[patent_app_country] => US
[patent_app_date] => 2024-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631959
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/631959 | Bacteriotherapy for clostridium difficile colitis | Apr 9, 2024 | Issued |
Array
(
[id] => 19345486
[patent_doc_number] => 20240254449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => SYSTEMS AND METHODS FOR GROWTH OF INTESTINAL CELLS IN MICROFLUIDIC DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/626855
[patent_app_country] => US
[patent_app_date] => 2024-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18626855
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/626855 | Systems and methods for growth of intestinal cells in microfluidic devices | Apr 3, 2024 | Issued |
Array
(
[id] => 19433857
[patent_doc_number] => 20240302355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => METHOD AND SYSTEM FOR DETERMINING INTEGRATED METABOLIC BASELINE AND POTENTIAL OF LIVING CELLS
[patent_app_type] => utility
[patent_app_number] => 18/609912
[patent_app_country] => US
[patent_app_date] => 2024-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609912
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/609912 | METHOD AND SYSTEM FOR DETERMINING INTEGRATED METABOLIC BASELINE AND POTENTIAL OF LIVING CELLS | Mar 18, 2024 | Pending |
Array
(
[id] => 19418378
[patent_doc_number] => 20240294501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => ISLET CELL MANUFACTURING COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/581700
[patent_app_country] => US
[patent_app_date] => 2024-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581700
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/581700 | Islet cell manufacturing compositions and methods of use | Feb 19, 2024 | Issued |
Array
(
[id] => 19447236
[patent_doc_number] => 20240307366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/581245
[patent_app_country] => US
[patent_app_date] => 2024-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581245
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/581245 | USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY | Feb 18, 2024 | Pending |
Array
(
[id] => 19447236
[patent_doc_number] => 20240307366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/581245
[patent_app_country] => US
[patent_app_date] => 2024-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581245
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/581245 | USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY | Feb 18, 2024 | Pending |
Array
(
[id] => 19431011
[patent_doc_number] => 20240299509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/437633
[patent_app_country] => US
[patent_app_date] => 2024-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18437633
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/437633 | NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS | Feb 8, 2024 | Pending |
Array
(
[id] => 19110460
[patent_doc_number] => 20240122210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => MICROBIAL COMPOSITIONS AND METHODS OF USE FOR IMPROVING MILK PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/394679
[patent_app_country] => US
[patent_app_date] => 2023-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394679
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/394679 | MICROBIAL COMPOSITIONS AND METHODS OF USE FOR IMPROVING MILK PRODUCTION | Dec 21, 2023 | Pending |
Array
(
[id] => 19098080
[patent_doc_number] => 20240117308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => METHOD FOR THE PRODUCTION OF THYMOCYTE SUPERNATANT
[patent_app_type] => utility
[patent_app_number] => 18/389801
[patent_app_country] => US
[patent_app_date] => 2023-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18389801
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/389801 | METHOD FOR THE PRODUCTION OF THYMOCYTE SUPERNATANT | Dec 19, 2023 | Pending |
Array
(
[id] => 20068570
[patent_doc_number] => 20250206792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-26
[patent_title] => METHOD TO PRODUCE PHOSPHORYLATED MILK PROTEINS IN MICROBES
[patent_app_type] => utility
[patent_app_number] => 18/390266
[patent_app_country] => US
[patent_app_date] => 2023-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18390266
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/390266 | METHOD TO PRODUCE PHOSPHORYLATED MILK PROTEINS IN MICROBES | Dec 19, 2023 | Pending |
Array
(
[id] => 19111245
[patent_doc_number] => 20240122995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS
[patent_app_type] => utility
[patent_app_number] => 18/544083
[patent_app_country] => US
[patent_app_date] => 2023-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18544083
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/544083 | Bacteriotherapy for clostridium difficile colitis | Dec 17, 2023 | Issued |
Array
(
[id] => 20142798
[patent_doc_number] => 12377113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Glycan therapeutic compositions and related methods thereof
[patent_app_type] => utility
[patent_app_number] => 18/535652
[patent_app_country] => US
[patent_app_date] => 2023-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 32
[patent_no_of_words] => 66314
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18535652
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/535652 | Glycan therapeutic compositions and related methods thereof | Dec 10, 2023 | Issued |
Array
(
[id] => 20171780
[patent_doc_number] => 12390500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Pharmaceutical composition of a recombinant adeno-associated virus vector and its application
[patent_app_type] => utility
[patent_app_number] => 18/515559
[patent_app_country] => US
[patent_app_date] => 2023-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1017
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18515559
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/515559 | Pharmaceutical composition of a recombinant adeno-associated virus vector and its application | Nov 20, 2023 | Issued |
Array
(
[id] => 19496467
[patent_doc_number] => 20240335485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/497412
[patent_app_country] => US
[patent_app_date] => 2023-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18497412
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/497412 | BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS | Oct 29, 2023 | Abandoned |